Create Alert
Watchlist

Sanofi India

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹11,835Cr
ROE42.11%
P/E Ratio(TTM)29.87
EPS(TTM)172.04
P/B Ratio13.75
Dividend Yield2.27%
Industry P/E34.34
Book Value373.70
Debt to Equity0.02
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Sanofi India

Sanofi India Limited is a healthcare company. The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It offers a range of medicines and supplements for treatment of diabetes (both insulin and orals), cardiology, thrombosis, epilepsy, allergies, and infections. It has two manufacturing sites, one in Hyderabad and one in Goa. Its geographical segments include India, Singapore, and Others. It sells its products through independent distributors primarily in India. It also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), eye/ear drops, ampoules, vials, creams, and ointment. Its brands include Lantus, Allegra, and Combiflam. Its vaccine products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT. Its consumer healthcare products include Allegra, Allegra nasal, and Avil.;
Parent OrganisationSanofi India Limited
Managing DirectorMr. Rodolfo Hrosz
NSE SymbolSANOFI

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
60.40%
Other Domestic Institutions
11.83%
Mutual Funds
11.22%
Retail And Others
10.94%
Foreign Institutions
5.61%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Abbott India
NA
(0.00%)
46.09
GlaxoSmithKline Pharmaceuticals
NA
(0.00%)
49.62
Pfizer
NA
(0.00%)
29.14
Astrazeneca Pharma India
NA
(0.00%)
115.48